Harrison Gunn

ID: 1b83cf65-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Alvotech and JAMP Pharma Receive Marketing Authorization for SIMLANDI in Canada

Big Molecule Watch · January 14, 2022

British Columbia Expands Biosimilar Initiative to Rapid-Acting Insulins

Big Molecule Watch · December 8, 2021

Ranibizumab Updates: FDA approval of Roche’s Refillable Ocular Implant and FDA Acceptance of Bioeq’s BQ201 BLA

Big Molecule Watch · November 8, 2021

FDA Accepts BeiGene’s BLA for Tislelizumab in Esophageal Squamous Cell Carcinoma

Big Molecule Watch · September 28, 2021

American Academy of Ophthalmology Pushes Back Against Bevacizumab Biosimilar Use in Treating Ophthalmic Conditions

Big Molecule Watch · August 19, 2021